Home Applications 216137 Application 216137
Type ANDA
Sponsor ZYDUS WORLDWIDE DMCC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE CAPSULE;ORAL 40MG No No 002 VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE CAPSULE;ORAL 60MG No No 003 VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE CAPSULE;ORAL 80MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A216137-001 VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE EQ 40MG BASE CAPSULE / ORAL 2024-08-07 A216137-002 VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE EQ 60MG BASE CAPSULE / ORAL 2024-08-07 A216137-003 VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE EQ 80MG BASE CAPSULE / ORAL 2024-08-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 48 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2024-10-29 15:01 UTC 2024-10 A216137-002 VALBENAZINE TOSYLATE EQ 60MG BASE CAPSULE / ORAL AB 2024-08-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A216137-003 VALBENAZINE TOSYLATE EQ 80MG BASE CAPSULE / ORAL AB 2024-08-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A216137-001 VALBENAZINE TOSYLATE EQ 40MG BASE CAPSULE / ORAL AB 2024-08-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A216137-002 VALBENAZINE TOSYLATE EQ 60MG BASE CAPSULE / ORAL AB 2024-08-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A216137-003 VALBENAZINE TOSYLATE EQ 80MG BASE CAPSULE / ORAL AB 2024-08-07 79d66fd596c7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216137-001 VALBENAZINE TOSYLATE EQ 40MG BASE CAPSULE / ORAL 2024-08-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216137-002 VALBENAZINE TOSYLATE EQ 60MG BASE CAPSULE / ORAL 2024-08-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216137-003 VALBENAZINE TOSYLATE EQ 80MG BASE CAPSULE / ORAL 2024-08-07 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 72935 ORIG 2022-12-20